what is human insulin?

Human insulin is a peptide hormone that plays a crucial role in regulating blood sugar levels in the human body. The pancreas produces it and helps cells absorb glucose from the bloodstream, providing energy. In medical contexts, human insulin can refer to insulin derived from human sources or produced using genetic engineering techniques known as recombinant DNA technology. This synthetic insulin is used to treat diabetes to replace or supplement the insufficient natural insulin produced by the body.

Human Insulin is available in the form of?

Human insulin is available in various forms, including Regular Insulin (Short-Acting), Intermediate-Acting Insulin, Long-Acting Insulin and Premixed Insulin. The specific form and combination of insulin prescribed depend on an individuals diabetes management plan, lifestyle and medical needs.

What is the primary factor propelling the market?

The increasing prevalence of diabetes worldwide significantly influences the global insulin market, with a rising number of diagnosed individuals leading to an expanding demand for insulin products.

What are the references?

World Health Organization, Center for Disease Control and Prevention, MedlinePlus(.gov), Food and Drug Administration, HHS.gov., Diabetes Education Online.

Insulin Market Overview | Growth | Share

Content

Introduction Research Methodology Executive Summary Market Overview Global Insulin Market Assessment Cross Segmentation A (Drug) Cross Segmentation B (Delivery Device) Company Profiles Conclusion & Recommendations

Introduction

Research Objective
Scope of the Study
Definition and Taxonomy

Research Methodology

Research Approach
Data Sources
Assumptions

Executive Summary

Synopsis
Analyst Recommendations

Market Overview

Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
Value Chain Analysis
- Raw Material Sourcing
- Manufacturing Process
- Logistics & Transportation
- Buyer Preferences
Trends
- Market Trends
- Technological Trends
Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitute
- Threat of New Entrants
- Degree of Competition
PESTLE Analysis for 5 Leading Countries
- Regulatory Framework for Leading Countries/Regions
- Supply Demand Analysis
- Production & Consumption Statistics
- Export Import Statistics
- Price Trend Analysis

Global Insulin Market Assessment

Segmentation A (Drug)

By Product
- Rapid-Acting (Fastest growing)
- Short-Acting
- Intermediate-Acting
- Premixed Long-Acting (Dominated)
By Source
- Human Insulin
- Insulin Analog (Dominated)
By Distribution Channel
- Hospital Pharmacies (Fastest Growing)
- Retail Pharmacies (Dominated)
- Online Pharmacies
By Application
- Type 1 Diabetes
- Type 2 Diabetes (Dominated)
- Gestational Diabetes (Significantly growing)

Segmentation B (Delivery Device)

By Delivery Device
- Insulin Pumps (Fastest)
- Insulin Pens (Dominated)
- Pen Needles & Syringes
- Others
By Distribution Channel
- Hospital Pharmacies (Fastest Growing)
- Retail Pharmacies (Dominated)
- Online Pharmacies
By Application
- Type 1 Diabetes
- Type 2 Diabetes (Dominated)
- Gestational Diabetes (Significantly growing)

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Cross Segmentation A (Drug)

By Product

Rapid-Acting (Fastest Growing)
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Short-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Intermediate-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Premixed
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Long-Acting (Dominated)
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa

By Source

Human Insulin
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Insulin Analog (Dominated)
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa

By Distribution Channel

Hospital Pharmacies (Fastest Growing)
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Retail Pharmacies (Dominated)
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Online Pharmacies
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa

By Application

Type 1 Diabetes
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Type 2 Diabetes (Dominated)
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Gestational Diabetes (Significantly growing)
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa

Cross Segmentation B (Delivery Device)

By Delivery Device

Insulin Pumps (Fastest Growing)
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Insulin Pens (Dominated)
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Pen Needles & Syringes
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Others
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa

By Distribution Channel

Hospital Pharmacies (Fastest Growing)
- By Delivery Device
  - Insulin Pumps
  - Insulin Pens
  - Pen Needles & Syringes
  - Others
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Retail Pharmacies (Dominated)
- By Delivery Device
  - Insulin Pumps
  - Insulin Pens
  - Pen Needles & Syringes
  - Others
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Online Pharmacies
- By Delivery Device
  - Insulin Pumps
  - Insulin Pens
  - Pen Needles & Syringes
  - Others
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa

By Application

Type 1 Diabetes
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Type 2 Diabetes (Dominated)
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa
Gestational Diabetes (Significantly growing)
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Region
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East and Africa

By Region

North America
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
Europe
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
Asia Pacific
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
Latin America
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes
Middle East and Africa
- By Product
  - Rapid-Acting
  - Short-Acting
  - Intermediate-Acting
  - Premixed
  - Long-Acting
- By Source
  - Human Insulin
  - Insulin Analog
- By Distribution Channel
  - Hospital Pharmacies
  - Retail Pharmacies
  - Online Pharmacies
- By Application
  - Type 1 Diabetes
  - Type 2 Diabetes
  - Gestational Diabetes

Company Profiles

Eli Lilly
- Company Overview
- Geographic Footprints
- Financial Performance
- Product Portfolio
- SWOT Analysis
- R&D Efforts
- Recent Developments & Strategic Collaborations
  - Product Launch/M&A/Technical Collaboration
Novo Nordisk
Sanofi
Boehringer Ingelheim
Biocon
Lupin Ltd.
Wockhardt Ltd.
Becton, Dickinson and Company
B. Braun SE

Conclusion & Recommendations

Insight Code: 5101
No. of Pages: 150+
Format: PDF/PPT/Excel
Published: January 2024
Report Covered: [Revenue + Volume]
Historical Year: 2021-2022
Base Year: 2023
Estimated Years: 2024-2033

Proceed To Buy

Global Deep Dive Analysis

USD 3800

Single Region (NA,EU,APAC,LA,MEA)

USD 2900

Databook

USD 1900

Cross-Sectional Analysis

USD 5500

We use cookies to improve your experience

Insulin Market Overview | Growth | Share | 4.2% - CAGR

Insulin Market Size Envisioned at USD 41.63 Billion by 2033